Shenzhen - Delayed Quote CNY

Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534.SZ)

7.62 +0.06 (+0.79%)
At close: 3:04 PM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
NameTitlePayExercisedYear Born
Mr. Qin Hui Yuan Deputy GM, Secretary of the Board & Non-Independent Director -- -- 1975
Mr. Yaowu Chen Deputy GM & Chief Engineer -- -- 1982
Mr. Shuangxi Qian GM & Director -- -- 1985

Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD

No. 10 Guofang Road
Dingyuan Town Yuzhong County
Lanzhou, 730102
China
86 93 1214 3336 https://www.lsrfzy.com
Sector: 
Healthcare
Full Time Employees: 
320

Description

Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD researches, develops, produces, and sells Chinese patent medicines, health food, and APIs in China and internationally. The company offers Xuanfei Zhicough mixture, Yuanhu Zhitong dropping pills, Qiwei Wenyang capsules, Maxing cough capsule, and Astragalus Angelica capsules. Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD was founded in 2002 and is based in Lanzhou, China.

Corporate Governance

Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

  • May 27, 2020
    Ex-Dividend Date

Upcoming Events